Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children

Amelia Licari, Ilaria Brambilla, Lucia Sacchi, Gianluigi Marseglia, Giorgio Ciprandi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Allergic asthma is characterized by type 2 inflammation. Periostin has been proposed as type 2 biomarker. Objective: To test the hypothesis that serum periostin could be associated with the asthma control grade in a group of children with allergic asthma and recruited in clinical practice. Patients and methods: 121 consecutive children (71 males, 50 females, mean age 11.6 ± 3.2 years) with allergic asthma were visited for the first time at a third-level paediatric clinic. Serum periostin was evaluated with gender, BMI and z score BMI, lung function, FeNO, ACT questionnaire, VAS of breathing perception, peripheral eosinophils, total serum IgE, oral corticosteroid (CS) use in the past year, control asthma grade and asthma severity (according to GINA document). Results: Serum periostin was not associated with the asthma control grade and did not correlate with blood eosinophils and FeNO. In addition, peripheral eosinophils, serum IgE, and FeNO were not associated with the asthma control grade. On the contrary, gender, FEV 1 , FEV 1 /FVC ratio, FEF 25-75 , ACT, VAS of breathing perception, oral corticosteroid use, and asthma severity grade were associated with the asthma control grade. Conclusions: Serum periostin seems to be scarcely useful to assess the asthma control in children with allergic asthma in clinical practice. There is the need to identify reliable inflammation biomarkers able to correlate with the asthma control grade.

Original languageEnglish
Pages (from-to)118-120
Number of pages3
JournalRespiratory Medicine
Volume151
DOIs
Publication statusPublished - May 1 2019

Fingerprint

Asthma
Biomarkers
Serum
Eosinophils
Immunoglobulin E
Adrenal Cortex Hormones
Respiration
Inflammation
Pediatrics
Lung

Keywords

  • Asthma
  • Asthma control
  • Children
  • Eosinophils
  • Inflammation
  • Periostin

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children. / Licari, Amelia; Brambilla, Ilaria; Sacchi, Lucia; Marseglia, Gianluigi; Ciprandi, Giorgio.

In: Respiratory Medicine, Vol. 151, 01.05.2019, p. 118-120.

Research output: Contribution to journalArticle

@article{066241d8ccf8483f85ada2dccf8dcaf7,
title = "Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children",
abstract = "Background: Allergic asthma is characterized by type 2 inflammation. Periostin has been proposed as type 2 biomarker. Objective: To test the hypothesis that serum periostin could be associated with the asthma control grade in a group of children with allergic asthma and recruited in clinical practice. Patients and methods: 121 consecutive children (71 males, 50 females, mean age 11.6 ± 3.2 years) with allergic asthma were visited for the first time at a third-level paediatric clinic. Serum periostin was evaluated with gender, BMI and z score BMI, lung function, FeNO, ACT questionnaire, VAS of breathing perception, peripheral eosinophils, total serum IgE, oral corticosteroid (CS) use in the past year, control asthma grade and asthma severity (according to GINA document). Results: Serum periostin was not associated with the asthma control grade and did not correlate with blood eosinophils and FeNO. In addition, peripheral eosinophils, serum IgE, and FeNO were not associated with the asthma control grade. On the contrary, gender, FEV 1 , FEV 1 /FVC ratio, FEF 25-75 , ACT, VAS of breathing perception, oral corticosteroid use, and asthma severity grade were associated with the asthma control grade. Conclusions: Serum periostin seems to be scarcely useful to assess the asthma control in children with allergic asthma in clinical practice. There is the need to identify reliable inflammation biomarkers able to correlate with the asthma control grade.",
keywords = "Asthma, Asthma control, Children, Eosinophils, Inflammation, Periostin",
author = "Amelia Licari and Ilaria Brambilla and Lucia Sacchi and Gianluigi Marseglia and Giorgio Ciprandi",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.rmed.2019.04.010",
language = "English",
volume = "151",
pages = "118--120",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children

AU - Licari, Amelia

AU - Brambilla, Ilaria

AU - Sacchi, Lucia

AU - Marseglia, Gianluigi

AU - Ciprandi, Giorgio

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Background: Allergic asthma is characterized by type 2 inflammation. Periostin has been proposed as type 2 biomarker. Objective: To test the hypothesis that serum periostin could be associated with the asthma control grade in a group of children with allergic asthma and recruited in clinical practice. Patients and methods: 121 consecutive children (71 males, 50 females, mean age 11.6 ± 3.2 years) with allergic asthma were visited for the first time at a third-level paediatric clinic. Serum periostin was evaluated with gender, BMI and z score BMI, lung function, FeNO, ACT questionnaire, VAS of breathing perception, peripheral eosinophils, total serum IgE, oral corticosteroid (CS) use in the past year, control asthma grade and asthma severity (according to GINA document). Results: Serum periostin was not associated with the asthma control grade and did not correlate with blood eosinophils and FeNO. In addition, peripheral eosinophils, serum IgE, and FeNO were not associated with the asthma control grade. On the contrary, gender, FEV 1 , FEV 1 /FVC ratio, FEF 25-75 , ACT, VAS of breathing perception, oral corticosteroid use, and asthma severity grade were associated with the asthma control grade. Conclusions: Serum periostin seems to be scarcely useful to assess the asthma control in children with allergic asthma in clinical practice. There is the need to identify reliable inflammation biomarkers able to correlate with the asthma control grade.

AB - Background: Allergic asthma is characterized by type 2 inflammation. Periostin has been proposed as type 2 biomarker. Objective: To test the hypothesis that serum periostin could be associated with the asthma control grade in a group of children with allergic asthma and recruited in clinical practice. Patients and methods: 121 consecutive children (71 males, 50 females, mean age 11.6 ± 3.2 years) with allergic asthma were visited for the first time at a third-level paediatric clinic. Serum periostin was evaluated with gender, BMI and z score BMI, lung function, FeNO, ACT questionnaire, VAS of breathing perception, peripheral eosinophils, total serum IgE, oral corticosteroid (CS) use in the past year, control asthma grade and asthma severity (according to GINA document). Results: Serum periostin was not associated with the asthma control grade and did not correlate with blood eosinophils and FeNO. In addition, peripheral eosinophils, serum IgE, and FeNO were not associated with the asthma control grade. On the contrary, gender, FEV 1 , FEV 1 /FVC ratio, FEF 25-75 , ACT, VAS of breathing perception, oral corticosteroid use, and asthma severity grade were associated with the asthma control grade. Conclusions: Serum periostin seems to be scarcely useful to assess the asthma control in children with allergic asthma in clinical practice. There is the need to identify reliable inflammation biomarkers able to correlate with the asthma control grade.

KW - Asthma

KW - Asthma control

KW - Children

KW - Eosinophils

KW - Inflammation

KW - Periostin

UR - http://www.scopus.com/inward/record.url?scp=85064162940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064162940&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2019.04.010

DO - 10.1016/j.rmed.2019.04.010

M3 - Article

AN - SCOPUS:85064162940

VL - 151

SP - 118

EP - 120

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

ER -